U.S. markets close in 5 hours 8 minutes
  • S&P 500

    4,245.61
    +35.37 (+0.84%)
     
  • Dow 30

    33,603.56
    +294.05 (+0.88%)
     
  • Nasdaq

    12,950.86
    +96.06 (+0.75%)
     
  • Russell 2000

    2,004.59
    +35.34 (+1.79%)
     
  • Crude Oil

    92.42
    +0.49 (+0.53%)
     
  • Gold

    1,807.50
    -6.20 (-0.34%)
     
  • Silver

    20.41
    -0.33 (-1.60%)
     
  • EUR/USD

    1.0339
    +0.0037 (+0.36%)
     
  • 10-Yr Bond

    2.8350
    +0.0490 (+1.76%)
     
  • GBP/USD

    1.2221
    +0.0003 (+0.03%)
     
  • USD/JPY

    132.6500
    -0.2230 (-0.17%)
     
  • BTC-USD

    24,521.98
    +485.98 (+2.02%)
     
  • CMC Crypto 200

    578.20
    +3.46 (+0.60%)
     
  • FTSE 100

    7,474.90
    -32.21 (-0.43%)
     
  • Nikkei 225

    27,819.33
    -180.63 (-0.65%)
     

Enovis to Host Second Quarter 2022 Conference Call on August 4th

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
Enovis Corporation
Enovis Corporation

Wilmington, DE, July 12, 2022 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its second quarter 2022 financial results on Thursday, August 4, 2022 at 8:00AM ET and issue an earnings press release earlier that morning. A presentation related to the call will be available on www.enovis.com in the “Investors” section.

Conference call/Webcast Information

Investors can access the live webcast via a link on the Enovis website. For those planning to participate on the call, please dial (800) 715-9871 (U.S. callers) and (646) 307-1963 (International callers) and provide the conference ID 1950250. A link to a replay of the call will also be available on the Enovis website later that day.

ABOUT ENOVIS

Enovis Corporation (NYSE: ENOV) is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services and integrated technologies fuels active lifestyles in orthopedics and beyond. The Company’s shares of common stock are listed in the United States on the New York Stock Exchange under the symbol ENOV. For more information about Enovis, please visit www.enovis.com.

Derek Leckow
Vice President, Investor Relations
Enovis Corporation
+1-302-421-1971
investorrelations@enovis.com

Source: Enovis Corporation